HDL in CKD: Not protective any longer

Kidney International

Volumn 85, Issue 3, 2014, Pages 712-

  Müller Deile, Janina ^a   Schmitt, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; INFLAMMATION; LETTER; PRIORITY JOURNAL; UREMIA; BLOOD; CHRONIC KIDNEY FAILURE; HYPERCHOLESTEROLEMIA; CARDIOVASCULAR DISEASE; HEMODIALYSIS; LIPID ANALYSIS; LIPID COMPOSITION; PROTEIN FUNCTION;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; HUMANS; HYPERCHOLESTEROLEMIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84895189488     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.523     Document Type: Letter

References (4)

1. Massy ZA, de Zeeuw D. LDL cholesterol in CKD-to treat or not to treat? Kidney Int 2013; 84: 451-456.
2. Yamamoto S, Yancey PG, Ikizler TA et al. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol 2012; 60: 2372-2379.
3. Holzer M, Birner-Gruenberger R, Stojakovic T et al. Uremia alters HDL composition and function. J Am Soc Nephrol 2011; 22: 1631-1641.
4. Speer T, Rohrer L, Blyszczuk P et al. Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like receptor-2. Immunity 2013; 38: 754-768.